Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,881 | -3,707 | -18,997 | -12,591 | -8,479 |
| Depreciation Amortization | 465 | 231 | 887 | 635 | 405 |
| Accounts receivable | 72 | 37 | -41 | -3 | -9 |
| Accounts payable and accrued liabilities | -357 | -455 | 370 | -263 | 1,254 |
| Other Working Capital | -1,856 | -1,641 | 1,355 | 212 | 954 |
| Other Operating Activity | -175 | 445 | 1,634 | 882 | -746 |
| Operating Cash Flow | $-11,732 | $-5,090 | $-14,791 | $-11,127 | $-6,620 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -18,576 | -13,688 | -18,576 |
| PPE Investments | -153 | -116 | -730 | -421 | -198 |
| Net Acquisitions | 5,136 | 5,136 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | 18,968 | 80 | 80 |
| Purchase Sale Intangibles | N/A | N/A | -205 | -206 | -117 |
| Other Investing Activity | 0 | 0 | -205 | -206 | -117 |
| Investing Cash Flow | $4,983 | $5,021 | $-542 | $-14,234 | $-18,811 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 320 | 316 | 20,887 | 19,583 | 19,549 |
| Financing Cash Flow | $320 | $316 | $20,887 | $19,583 | $19,549 |
| Beginning Cash Position | 28,020 | 28,020 | 22,467 | 22,467 | 22,467 |
| End Cash Position | 21,592 | 28,267 | 28,020 | 16,688 | 16,585 |
| Net Cash Flow | $-6,429 | $247 | $5,553 | $-5,779 | $-5,882 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,732 | -5,090 | -14,791 | -11,127 | -6,620 |
| Capital Expenditure | -153 | -116 | -730 | -421 | -198 |
| Free Cash Flow | -11,885 | -5,206 | -15,521 | -11,548 | -6,818 |